1. Home
  2. GOVX vs ZBAI Comparison

GOVX vs ZBAI Comparison

Compare GOVX & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • ZBAI
  • Stock Information
  • Founded
  • GOVX 2001
  • ZBAI 2015
  • Country
  • GOVX United States
  • ZBAI United States
  • Employees
  • GOVX N/A
  • ZBAI N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • ZBAI Professional Services
  • Sector
  • GOVX Health Care
  • ZBAI Consumer Discretionary
  • Exchange
  • GOVX Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • GOVX 15.5M
  • ZBAI 17.3M
  • IPO Year
  • GOVX N/A
  • ZBAI N/A
  • Fundamental
  • Price
  • GOVX $0.48
  • ZBAI $0.33
  • Analyst Decision
  • GOVX Strong Buy
  • ZBAI
  • Analyst Count
  • GOVX 5
  • ZBAI 0
  • Target Price
  • GOVX $12.40
  • ZBAI N/A
  • AVG Volume (30 Days)
  • GOVX 2.5M
  • ZBAI 2.5M
  • Earning Date
  • GOVX 08-05-2025
  • ZBAI 06-06-2025
  • Dividend Yield
  • GOVX N/A
  • ZBAI N/A
  • EPS Growth
  • GOVX N/A
  • ZBAI N/A
  • EPS
  • GOVX N/A
  • ZBAI N/A
  • Revenue
  • GOVX $5,591,576.00
  • ZBAI $720,000.00
  • Revenue This Year
  • GOVX N/A
  • ZBAI N/A
  • Revenue Next Year
  • GOVX N/A
  • ZBAI N/A
  • P/E Ratio
  • GOVX N/A
  • ZBAI N/A
  • Revenue Growth
  • GOVX N/A
  • ZBAI 44.00
  • 52 Week Low
  • GOVX $0.43
  • ZBAI $0.27
  • 52 Week High
  • GOVX $11.18
  • ZBAI $2.50
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 28.87
  • ZBAI N/A
  • Support Level
  • GOVX $0.43
  • ZBAI N/A
  • Resistance Level
  • GOVX $0.98
  • ZBAI N/A
  • Average True Range (ATR)
  • GOVX 0.15
  • ZBAI 0.00
  • MACD
  • GOVX -0.06
  • ZBAI 0.00
  • Stochastic Oscillator
  • GOVX 4.87
  • ZBAI 0.00

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: